1. Home
  2. JSPR vs DOMO Comparison

JSPR vs DOMO Comparison

Compare JSPR & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPR
  • DOMO
  • Stock Information
  • Founded
  • JSPR 2018
  • DOMO 2010
  • Country
  • JSPR United States
  • DOMO United States
  • Employees
  • JSPR N/A
  • DOMO N/A
  • Industry
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • DOMO Computer Software: Prepackaged Software
  • Sector
  • JSPR Health Care
  • DOMO Technology
  • Exchange
  • JSPR Nasdaq
  • DOMO Nasdaq
  • Market Cap
  • JSPR 85.8M
  • DOMO 562.5M
  • IPO Year
  • JSPR N/A
  • DOMO 2018
  • Fundamental
  • Price
  • JSPR $3.51
  • DOMO $14.11
  • Analyst Decision
  • JSPR Buy
  • DOMO Hold
  • Analyst Count
  • JSPR 12
  • DOMO 6
  • Target Price
  • JSPR $31.67
  • DOMO $12.17
  • AVG Volume (30 Days)
  • JSPR 1.4M
  • DOMO 660.7K
  • Earning Date
  • JSPR 08-12-2025
  • DOMO 08-28-2025
  • Dividend Yield
  • JSPR N/A
  • DOMO N/A
  • EPS Growth
  • JSPR N/A
  • DOMO N/A
  • EPS
  • JSPR N/A
  • DOMO N/A
  • Revenue
  • JSPR N/A
  • DOMO $317,052,000.00
  • Revenue This Year
  • JSPR N/A
  • DOMO $1.71
  • Revenue Next Year
  • JSPR N/A
  • DOMO $2.43
  • P/E Ratio
  • JSPR N/A
  • DOMO N/A
  • Revenue Growth
  • JSPR N/A
  • DOMO N/A
  • 52 Week Low
  • JSPR $2.27
  • DOMO $6.01
  • 52 Week High
  • JSPR $26.05
  • DOMO $15.42
  • Technical
  • Relative Strength Index (RSI)
  • JSPR 37.54
  • DOMO 56.79
  • Support Level
  • JSPR $2.71
  • DOMO $14.20
  • Resistance Level
  • JSPR $4.00
  • DOMO $15.42
  • Average True Range (ATR)
  • JSPR 0.67
  • DOMO 0.81
  • MACD
  • JSPR -0.28
  • DOMO -0.07
  • Stochastic Oscillator
  • JSPR 29.21
  • DOMO 62.03

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: